STONEYBURN HEALTHCARE LIMITEDActive

Company number SC308873Private limited companyIncorporated 2006

Key figures

£197,146+65.5%
Net assets 2025
-100 k0100 k200 k2019/202020/212021/222022/232023/242025

Like most small UK companies, STONEYBURN HEALTHCARE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242025
Filed accounts2019/20–2025
2020/212021/222022/232023/242025
Turnover806,9521,045,3621,048,674——
Cash at bank and in hand43,06866,506108,69267,72259,003
Total assets296,357430,899224,534177,914286,060
Total liabilities416,835339,723109,40758,810128,722
Net assets / total equity120,47891,176125,052119,104197,146
Average number of employees47550

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: STONEYBURN HEALTHCARE LIMITED

Company

STONEYBURN HEALTHCARE LIMITED is a private limited company registered with Companies House under company number SC308873. It was incorporated on 20 Sep 2006. Its status is active. The registered office is in Tranent (EH33). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £197,146, up 65.5% on the previous year. Cash at bank and in hand was £59,003. Total assets were £286,060 and total liabilities £128,722. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2025).

Control and charges

One person with significant control is registered. 4 of 8 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 28 Nov 2026.